A nurse caring for a client”who has hypertension and asks the nurse about a prescription for propranolol. The nurse should inform the client that this medication is contraindicated in clients who have a history of which of the following conditions?

A) Bicarbonate:
While bicarbonate levels may be relevant in some cases, they are not typically a primary consideration before administering furosemide. Furosemide primarily affects electrolyte balance, particularly potassium and sodium, rather than bicarbonate levels.

B) Potassium:
This is the correct answer. Before administering furosemide, it is essential to review the client's potassium levels because furosemide is a loop diuretic that can lead to potassium depletion. Monitoring potassium levels helps prevent hypokalemia, which can lead to cardiac dysrhythmias and other complications, especially in clients with heart failure.

C) Phosphate:
Phosphate levels are not typically a primary concern before administering furosemide. Furosemide primarily affects sodium and potassium levels rather than phosphate levels.

D) Carbon dioxide:
Carbon dioxide levels are not typically a primary consideration before administering furosemide. Furosemide primarily affects electrolyte balance rather than carbon dioxide levels.

A) STAT administration of atropine:
This is the correct answer. Atropine is a cholinergic antagonist that can increase heart rate by blocking the action of acetylcholine on cardiac muscarinic receptors. In cases of severe bradycardia, especially if associated with symptoms such as dizziness, syncope, or hypotension, atropine is often administered to increase heart rate and improve cardiac output. The dose of atropine and frequency of administration depend on the severity of bradycardia and the clinical response.

B) Administration of activated charcoal:
Activated charcoal is used in cases of overdose or poisoning to absorb ingested toxins and prevent their absorption into the bloodstream. However, in this scenario, where the primary concern is bradycardia resulting from cholinesterase inhibitor (donepezil) toxicity, activated charcoal would not be effective in reversing the bradycardic effects of the medication.

C) Hemodialysis:
Hemodialysis is a renal replacement therapy used to remove toxins and waste products from the blood in individuals with kidney failure. While hemodialysis may be indicated in cases of severe drug overdose or poisoning to enhance toxin elimination, it is not typically used as a first-line intervention for bradycardia associated with cholinesterase inhibitor toxicity.

D) Intravenous administration of pseudoephedrine:
Pseudoephedrine is a sympathomimetic drug that acts as a vasoconstrictor and can increase heart rate and blood pressure. While it may be used to treat bradycardia in some cases, such as severe symptomatic bradycardia unresponsive to atropine, it is not the first-line treatment for cholinesterase inhibitor toxicity-induced bradycardia. Atropine is preferred due to its direct antagonism of muscarinic receptors in the heart.